Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OATD-01 in active pulmonary sarcoidosis
NL-OMON58902Phase 2Not yet recruiting
- Sponsor
- Molecure
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of OATD-01 in pulmonary sarcoidosis, sponsored by Molecure. Primary endpoint: Response to treatment from baseline to end of treatment. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
OATD-01
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NL-OMON58902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58902.